Fridays and Mounjaro: Brand Tirzepatide vs the Compounded Route

This article is part of the PlexusDx Education Hub, where we publish evidence-based guidance on GLP-1 therapies, weight management protocols, and the genetic factors behind every metabolic decision. Browse all Peptides & GLP-1 education

This editorial review clarifies how Fridays relates to Mounjaro and tirzepatide, the difference between the brand and the compounded compound, and the genetic variable a prescription leaves out. Fair-balance editorial framing, not a buying recommendation. As of April 2026.

Full head-to-head: PlexusDx vs Fridays →

This is an independent editorial review. PlexusDx holds no commercial relationship with Fridays, earns no affiliate commission, and was not compensated to publish it.

Mounjaro, tirzepatide, and what Fridays actually dispenses

Mounjaro is the brand name for tirzepatide, so a search for Fridays and Mounjaro is really a question about tirzepatide access. Fridays (Fridays Health) is a telehealth-plus-compounding service: a licensed provider reviews your intake and issues a prescription filled at a retail pharmacy for a brand product or a 503A compounding pharmacy for compounded tirzepatide. The compounded route is what the program is built around. Program details sit at Fridays' own website.

Branded Mounjaro versus compounded tirzepatide

Tirzepatide is a dual GIP and GLP-1 receptor agonist. In brand form it is Mounjaro, FDA-approved and manufactured by the originator. Compounded tirzepatide is prepared by a 503A pharmacy for an individual patient under prescription. The active molecule is the same class, but manufacturing, regulatory status, and price differ, and telehealth pricing typically reflects the compounded version.

Why the distinction matters at checkout

Confusing the two can distort a cost comparison. A quote for compounded tirzepatide is not comparable to a retail brand price, and assuming otherwise makes any program look cheaper or dearer than it is.

How a telehealth program routes a tirzepatide prescription

The flow is consistent across the category: intake covering weight, history, and medications; clinical review; a prescription routed to the appropriate pharmacy; then follow-up for titration and side effects. Where programs differ is provider type and pharmacy partner, which is what shapes both experience and price.

What the tirzepatide trials measured

The evidence base for tirzepatide comes largely from the SURMOUNT program for weight management (published in The New England Journal of Medicine, 2022) and SURMOUNT-OSA for obstructive sleep apnea (NEJM 2024). Trial populations and endpoints vary, and individual outcomes vary too. On pricing, Fridays lists compounded tirzepatide at $359 monthly (joinfridays.com/pricing, verified 2026-07-20), with rates that moved within a single day.

The tirzepatide variable a prescription cannot see

Two people on identical tirzepatide plans can travel very different paths, and the reason often sits upstream in the genome. Variants in GLP1R, the GLP-1 receptor gene tirzepatide engages alongside the GIP receptor, and in MC4R, a satiety-linked receptor, describe the terrain the compound acts on. They never predict how anyone responds to tirzepatide, but they add pathway context an intake form omits. The Precision Peptide Genetic Test reads 14 pathways, 49 peptides, 150+ genetic insights, including FTO, MC4R, and TCF7L2.

PlexusDx tirzepatide options and genetic context

PlexusDx offers tirzepatide through its Weight Management Protocols as Tirzepatide Injection and an oral format, paired with the Precision Peptide Genetic Test so the compound arrives with context, not just a dose.

No affiliation: PlexusDx is independent of Fridays and has no commercial ties to the brands discussed in this review.

More from the PlexusDx library: GLP-1 vs Mounjaro, Mounjaro Injection.

Disclaimer: this article is educational. PlexusDx is not affiliated with Fridays and has no commercial relationship with the brands reviewed. PlexusDx offers semaglutide and tirzepatide through its own Weight Management Protocols, and this piece compares approaches within the GLP-1 telehealth space. The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways; it does not predict response to any specific medication and is not a pharmacogenomic test. Speak with a qualified healthcare provider before beginning any peptide protocol.

Frequently Asked Questions About Fridays and Mounjaro

Does Fridays prescribe Mounjaro?

Mounjaro is Eli Lilly's FDA-approved brand of tirzepatide. Telehealth programs like Fridays more commonly dispense compounded tirzepatide through a 503A pharmacy rather than brand Mounjaro. A provider can route a prescription to retail for a brand product, but the compounded route is what the program pricing reflects.

What is the difference between Mounjaro and compounded tirzepatide?

Both contain tirzepatide, a dual GIP and GLP-1 receptor agonist. Mounjaro is the FDA-approved, brand-manufactured product; compounded tirzepatide is prepared by a 503A pharmacy under a prescription. They differ in manufacturing, oversight, and price rather than in the active molecule itself.

How much does tirzepatide cost through Fridays?

On its pricing page (joinfridays.com/pricing, verified 2026-07-20), Fridays lists compounded tirzepatide at $359 monthly month-to-month, with annual prepay near $240. Brand Mounjaro filled at retail carries separate, generally higher pricing. Rates moved within a single day, so confirm the live figure before committing.

Can genetics tell me if tirzepatide will work?

No. The Precision Peptide Genetic Test never predicts response to tirzepatide or any medication. It reads pathway variants such as MC4R to describe your baseline metabolism, context you and a provider can weigh alongside the clinical decision to start a compound.

This article is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education